Fertility and Maternal Health Drugs Advisory Committee
Executive Summary
Will meet Oct. 26-27 in Conference Rooms D and E at Parklawn. On Oct. 26, committee will discuss eliminating or raising the upper age limits currently observed for the use of oral contraceptives. The Oct. 27 session will review NDA for TPA's Lupron (leuprolide) in the treatment of leiomyomata uteri. Meetings start at 9 a.m.